Skip to main content
Erschienen in: International Urology and Nephrology 4/2012

01.08.2012 | Nephrology – Original Paper

Prevalence of intracranial artery calcification in hemodialysis patients—a case–control study

verfasst von: Yuko Iwasa, Shigeru Otsubo, Kazuomi Nomoto, Naobumi Yashiro, Aiji Yajima, Naoki Kimata, Takashi Akiba, Kosaku Nitta

Erschienen in: International Urology and Nephrology | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Intracranial artery calcification has been reported to be an independent risk factor for ischemic stroke. Also, existence of a positive correlation has been reported between the presence of arterial calcification and that of ischemic changes in the area supplied by such arteries. While intracranial artery calcification has frequently been observed on computed tomographic (CT) images of the brain in hemodialysis patients, its prevalence has not been reported previously. We investigated our hemodialysis outpatients to determine the prevalence of intracranial artery calcification in these patients in comparison with that in healthy controls.

Methods

Brain CT examinations were performed in 107 patients under maintenance hemodialysis therapy. For comparison, 43 representatives of the general population who underwent a brain CT examination as part of a health checkup were also studied as control subjects.

Results

Intracranial calcifications were more frequently found among hemodialysis patients (87.9%) than among control subjects (53.5%, P = 0.0003), and the prevalences of calcification in each of the intracranial arteries in the two groups were as follows: vertebral artery (65.5% vs. 25.6%, P = 0.0002), internal carotid artery (62.1% vs. 18.6%, P < 0.0001), basilar artery (34.5% vs. 34.9%, ns), anterior cerebral artery (0 vs. 2.3%, ns), middle cerebral artery (24.1% vs. 20.9%, ns), and posterior cerebral artery (5.2% vs. 4.7%, ns).

Conclusions

A much higher rate of intracranial artery calcification was observed in hemodialysis patients than in the general population, and the most frequently involved sites of calcification in these patients were the relatively large intracranial arteries.
Literatur
1.
Zurück zum Zitat Chen XY, Lam WW, Ng HK, Fan YH et al (2007) Intracranial artery calcification: a newly identified risk factor of ischemic stroke. J Neuroimaging 17:300–303PubMedCrossRef Chen XY, Lam WW, Ng HK, Fan YH et al (2007) Intracranial artery calcification: a newly identified risk factor of ischemic stroke. J Neuroimaging 17:300–303PubMedCrossRef
2.
Zurück zum Zitat Sohn YH, Cheon HY, Jeon P et al (2004) Clinical implication of cerebral artery calcification on brain CT. Cerebrovasc Dis 18(4):332–337PubMedCrossRef Sohn YH, Cheon HY, Jeon P et al (2004) Clinical implication of cerebral artery calcification on brain CT. Cerebrovasc Dis 18(4):332–337PubMedCrossRef
3.
Zurück zum Zitat Erbay S, Han R, Baccei S et al (2007) Intracranial carotid artery calcification on head CT and its association with ischemic changes on brain MRI in patients presenting with stroke-like symptoms: retrospective analysis. Neuroradiology 49(1):27–33PubMedCrossRef Erbay S, Han R, Baccei S et al (2007) Intracranial carotid artery calcification on head CT and its association with ischemic changes on brain MRI in patients presenting with stroke-like symptoms: retrospective analysis. Neuroradiology 49(1):27–33PubMedCrossRef
4.
Zurück zum Zitat Daghighi MH, Rezaei V, Zarrintan S et al (2007) Intracranial physiological calcifications in adults on computed tomography in Tabriz, Iran. Folia Morphol (Warsz) 66(2):115–119 Daghighi MH, Rezaei V, Zarrintan S et al (2007) Intracranial physiological calcifications in adults on computed tomography in Tabriz, Iran. Folia Morphol (Warsz) 66(2):115–119
5.
Zurück zum Zitat Yamazaki Y, Okazaki R, Shibata M et al (2002) Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. J Clin Endocrinol Metab 87:4957–4960PubMedCrossRef Yamazaki Y, Okazaki R, Shibata M et al (2002) Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. J Clin Endocrinol Metab 87:4957–4960PubMedCrossRef
6.
Zurück zum Zitat Daghighi MH, Rezaei V, Zarrintan S et al (2007) Intracranial physiological calcifications in adults on computed tomography in Tabriz, Iran. Folia Morphol 66:115–119 Daghighi MH, Rezaei V, Zarrintan S et al (2007) Intracranial physiological calcifications in adults on computed tomography in Tabriz, Iran. Folia Morphol 66:115–119
7.
Zurück zum Zitat Bugnicourt JM, Chillon JM, Tribouilloy C et al (2010) Relation between intracranial artery calcifications and aortic atherosclerosis in ischemic stroke patients. J Neurol 257:1338–1343PubMedCrossRef Bugnicourt JM, Chillon JM, Tribouilloy C et al (2010) Relation between intracranial artery calcifications and aortic atherosclerosis in ischemic stroke patients. J Neurol 257:1338–1343PubMedCrossRef
8.
Zurück zum Zitat Woodcock RJ, Goldstein JH, Kallmes DF et al (1999) Angiographic correlation of CT calcification in the carotid siphon. Am J Neuroradiol 20:495–499PubMed Woodcock RJ, Goldstein JH, Kallmes DF et al (1999) Angiographic correlation of CT calcification in the carotid siphon. Am J Neuroradiol 20:495–499PubMed
9.
Zurück zum Zitat McCullough PA, Agrawal V, Danielewicz E et al (2008) Accelerated atherosclerotic calcification and Monckeberg’s sclerosis: a continuum of advanced vascular pathology in chronic kidney disease. Clin J Am Soc Nephrol 3:1585–1598PubMedCrossRef McCullough PA, Agrawal V, Danielewicz E et al (2008) Accelerated atherosclerotic calcification and Monckeberg’s sclerosis: a continuum of advanced vascular pathology in chronic kidney disease. Clin J Am Soc Nephrol 3:1585–1598PubMedCrossRef
10.
Zurück zum Zitat Iwasa Y, Otsubo S, Yajima A, et al. (2011) Intracranial artery calcification in hemodialysis patients. Int Urol Nephrol 43:585–588 Iwasa Y, Otsubo S, Yajima A, et al. (2011) Intracranial artery calcification in hemodialysis patients. Int Urol Nephrol 43:585–588
11.
Zurück zum Zitat Matsumoto M (2004) Vascular dysfunctions in metabolic syndrome. A risk for cerebrovascular disorders. Nippon Naika Gakkai Zasshi 93:662–669PubMedCrossRef Matsumoto M (2004) Vascular dysfunctions in metabolic syndrome. A risk for cerebrovascular disorders. Nippon Naika Gakkai Zasshi 93:662–669PubMedCrossRef
12.
Zurück zum Zitat Canalejo R, Canalejo A, Martinez-Moreno JM et al (2010) FGF23 fails to inhibit uremic parathyroid glands. J Am Soc Nephrol 21:1125–1135PubMedCrossRef Canalejo R, Canalejo A, Martinez-Moreno JM et al (2010) FGF23 fails to inhibit uremic parathyroid glands. J Am Soc Nephrol 21:1125–1135PubMedCrossRef
13.
Zurück zum Zitat Nasrallah MM, El-Shehaby AR, Salem MM et al (2010) Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients. Nephrol Dial Transpl 25:2679–2685CrossRef Nasrallah MM, El-Shehaby AR, Salem MM et al (2010) Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients. Nephrol Dial Transpl 25:2679–2685CrossRef
14.
Zurück zum Zitat Jean G, Terrat JC, Vanel T et al (2009) High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients. Nephrol Dial Transpl 24:2792–2796CrossRef Jean G, Terrat JC, Vanel T et al (2009) High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients. Nephrol Dial Transpl 24:2792–2796CrossRef
15.
Zurück zum Zitat Jean G, Bresson E, Terrat JC et al (2009) Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences. Nephrol Dial Transpl 24:948–955CrossRef Jean G, Bresson E, Terrat JC et al (2009) Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences. Nephrol Dial Transpl 24:948–955CrossRef
16.
Zurück zum Zitat Roos M, Lutz J, Salmhofer H et al (2008) Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function. Clin Endocliol 68:660–665CrossRef Roos M, Lutz J, Salmhofer H et al (2008) Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function. Clin Endocliol 68:660–665CrossRef
17.
Zurück zum Zitat Inaba M, Okuno S, Imanishi Y et al (2006) Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients. Osteoporos Int 17:1506–1513PubMedCrossRef Inaba M, Okuno S, Imanishi Y et al (2006) Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients. Osteoporos Int 17:1506–1513PubMedCrossRef
18.
Zurück zum Zitat Kojima F, Uchida K, Ogawa T et al (2008) Plasma levels of fibroblast growth factor-23 and mineral metabolism in diabetic and non-diabetic patients on chronic hemodialysis. Int Urol Nephrol 40:1067–1074PubMedCrossRef Kojima F, Uchida K, Ogawa T et al (2008) Plasma levels of fibroblast growth factor-23 and mineral metabolism in diabetic and non-diabetic patients on chronic hemodialysis. Int Urol Nephrol 40:1067–1074PubMedCrossRef
Metadaten
Titel
Prevalence of intracranial artery calcification in hemodialysis patients—a case–control study
verfasst von
Yuko Iwasa
Shigeru Otsubo
Kazuomi Nomoto
Naobumi Yashiro
Aiji Yajima
Naoki Kimata
Takashi Akiba
Kosaku Nitta
Publikationsdatum
01.08.2012
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 4/2012
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-011-0026-7

Weitere Artikel der Ausgabe 4/2012

International Urology and Nephrology 4/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.